{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:40:55Z","timestamp":1791222055517,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.semnephrol.2016.02.001","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T19:00:49Z","timestamp":1464202849000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":175,"title":["Iron Balance and the Role of Hepcidin in Chronic Kidney Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Tomas","family":"Ganz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeta","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2016.02.001_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2007-12-077388","article-title":"Forging a field: the golden age of iron biology","volume":"112","author":"Andrews","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib3","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","article-title":"Systemic iron homeostasis","volume":"93","author":"Ganz","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.beha.2004.08.022","article-title":"Diagnosis and management of iron-deficiency anaemia","volume":"18","author":"Cook","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib5","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3945\/ajcn.2008.27151","article-title":"Assessment of iron deficiency in US preschool children and nonpregnant females of childbearing age: National Health and Nutrition Examination Survey 2003-2006","volume":"89","author":"Cogswell","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib6","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1182\/blood-2006-08-041830","article-title":"Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias","volume":"109","author":"Chen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib7","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood.V95.9.2975.009k03_2975_2982","article-title":"The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation","volume":"95","author":"Breuer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cmet.2015.05.002","article-title":"SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis","volume":"22","author":"Jenkitkasemwong","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib9","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphar.2014.00104","article-title":"Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis","volume":"5","author":"Core","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cmet.2008.09.012","article-title":"The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin","volume":"8","author":"Silvestri","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2010-06-287292","article-title":"Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein","volume":"117","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chom.2014.12.001","article-title":"Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus","volume":"17","author":"Arezes","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2012-02-411470","article-title":"Induction of activin B by inflammatory stimuli upregulates expression of the iron-regulatory peptide hepcidin through Smad1\/5\/8 signaling","volume":"120","author":"Besson-Fournier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3324\/haematol.2009.013136","article-title":"Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin","volume":"95","author":"Ashby","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1749-6632.2009.05038.x","article-title":"Maintaining mammalian iron and oxygen homeostasis: sensors, regulation, and cross-talk","volume":"1177","author":"Salahudeen","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bbrc.2005.08.111","article-title":"Signalling hypoxia by HIF hydroxylases","volume":"338","author":"Schofield","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/j.gastro.2013.12.031","article-title":"Hypoxia-inducible factors link iron homeostasis and erythropoiesis","volume":"146","author":"Shah","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib21","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1172\/JCI63924","article-title":"Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis","volume":"122","author":"Liu","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib22","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib23","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","article-title":"Immunoassay for human serum hepcidin","volume":"112","author":"Ganz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib24","doi-asserted-by":"crossref","first-page":"e58934","DOI":"10.1371\/journal.pone.0058934","article-title":"Cellular catabolism of the iron-regulatory peptide hormone hepcidin","volume":"8","author":"Preza","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib25","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2005-04-1766","article-title":"Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs","volume":"106","author":"Rivera","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2005-05-2049","article-title":"The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study","volume":"107","author":"Nemeth","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib27","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1373\/clinchem.2010.149187","article-title":"Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders","volume":"56","author":"Kroot","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib28","article-title":"The three isoforms of hepcidin in human serum and their processing determined by liquid chromatography-tandem mass spectrometry (LC-tandem MS)","author":"Addo","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib29","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib30","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/ndt\/gft338","article-title":"Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics","volume":"28","author":"Minutolo","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000189100","article-title":"Iron absorption in patients with chronic uremia on maintenance hemodialysis and in healthy volunteers measured with a simple oral iron load test","volume":"73","author":"Goch","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2215\/CJN.05931108","article-title":"Hepcidin\u2013a potential novel biomarker for iron status in chronic kidney disease","volume":"4","author":"Zaritsky","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.thromres.2005.03.032","article-title":"Uremic bleeding: pathophysiology and clinical risk factors","volume":"118","author":"Sohal","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00467-014-2991-4","article-title":"Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort","volume":"30","author":"Atkinson","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib35","doi-asserted-by":"crossref","first-page":"e99781","DOI":"10.1371\/journal.pone.0099781","article-title":"The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease","volume":"9","author":"Mercadel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/jcla.21634","article-title":"Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates","volume":"27","author":"Troutt","year":"2013","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib37","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2215\/CJN.08161109","article-title":"Reduction of serum hepcidin by hemodialysis in pediatric and adult patients","volume":"5","author":"Zaritsky","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000312381","article-title":"Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation","volume":"31","author":"Kuragano","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib39","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood.V82.4.1377a.1377a","article-title":"Functional iron deficiency","volume":"82","author":"Cavill","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1440-1797.2007.00810.x","article-title":"Erythropoiesis-stimulating agent hyporesponsiveness","volume":"12","author":"Johnson","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib41","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2215\/CJN.02380607","article-title":"Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets","volume":"2","author":"Fishbane","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0272-6386(95)90151-5","article-title":"Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation","volume":"26","author":"Fishbane","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/blood-2009-10-251496","article-title":"Iron control of erythroid development by a novel aconitase-associated regulatory pathway","volume":"116","author":"Bullock","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib44","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1093\/emboj\/20.23.6909","article-title":"Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency","volume":"20","author":"Han","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib45","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ajh.21279","article-title":"Serum transferrin receptor","volume":"83","author":"Skikne","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib46","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib47","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RHU.0b013e31829ce01f","article-title":"Causes and significance of markedly elevated serum ferritin levels in an academic medical center","volume":"19","author":"Moore","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcmd.2003.08.003","article-title":"The ferroportin disease. Blood","volume":"32","author":"Pietrangelo","year":"2004","journal-title":"Cell Mol Dis"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MOH.0b013e32835f5933","article-title":"Red cell indices in classification and treatment of anemias: from M.M. Wintrobes\u02bcs original 1934 classification to the third millennium","volume":"20","author":"Brugnara","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib50","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69057.x","article-title":"Erythrocyte zinc protoporphyrin","volume":"69","author":"Braun","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib51","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood-2013-08-522466","article-title":"Anti-hepcidin therapy for iron-restricted anemias","volume":"122","author":"Nemeth","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2015.06.030","article-title":"New treatment approaches for the anemia of CKD","volume":"67","author":"Bonomini","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.02.001_bib53","article-title":"Roxadustat (FG-4592): correction of anemia in incident dialysis patients","author":"Besarab","year":"2015","journal-title":"J Am Soc Nephrol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:39:21Z","timestamp":1600648761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929516000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0270929516000127"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.02.001","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron Balance and the Role of Hepcidin in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}